BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20832135)

  • 21. [Occupational differences in exposure to hazardous work conditions].
    Marinacci C; d'Errico A; Cardano M; Perini F; Costa G
    Med Lav; 2005; 96 Suppl():s127-40. PubMed ID: 15871624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The implementation of legislation acts regarding prevention of occupational exposure to bloodborne pathogens from perspective of Poland as the ue country].
    Szczeniowski A; Gańczak M
    Med Pr; 2011; 62(1):57-66. PubMed ID: 21748884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Finnish discourses of the stakeholders on development of the implementation of EU legislation concerned with occupational safety and health in computer work.
    Niskanen T; Lehtelä J
    Int J Occup Saf Ergon; 2015; 21(4):413-25. PubMed ID: 26327151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Motivating instruments behind occupational health activities and their efficiency in expert judgment].
    Rydlewska-Liszkowska I
    Med Pr; 2009; 60(6):451-7. PubMed ID: 20187493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drafting guidelines for occupational exposure to chemicals: the Dutch experience with the assessment of reproductive risks.
    Stijkel A; van Eijndhoven JC; Bal R
    Am J Ind Med; 1996 Dec; 30(6):705-17. PubMed ID: 8914717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involving stakeholders and developing a policy for stakeholder involvement in the European network for health technology assessment, EUnetHTA.
    Nielsen CP; Lauritsen SW; Kristensen FB; Bistrup ML; Cecchetti A; Turk E;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():84-91. PubMed ID: 20030895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modern regulatory impact analysis: the experience of the European Union.
    Ballantine B; Devonald B
    Regul Toxicol Pharmacol; 2006 Feb; 44(1):57-68. PubMed ID: 16307835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The state of occupational health in community Europe: from top-down reform to a renewal of trade union action?
    Vogel L
    New Solut; 2003; 13(2):133-47. PubMed ID: 17208872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Models of workers' health and safety insurance in the selected European Union member states: certain economic problems].
    Rydlewska-Liszkowska I
    Med Pr; 2007; 58(6):511-9. PubMed ID: 18421933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspectives on Drug and Therapeutics Committee policy implementation.
    Tan EL; Day RO; Brien JA
    Res Social Adm Pharm; 2005 Dec; 1(4):526-45. PubMed ID: 17138494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Affected parents' and other stakeholders' perception of a fire disaster management in India: a situational analysis.
    Satapathy S; Walia A
    Disaster Manag Response; 2007; 5(4):111-8. PubMed ID: 17996655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Occupational data cards as a source of information for health prevention purposes].
    Bugajska J
    Med Pr; 2000; 51(6):551-61. PubMed ID: 11288683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The European Directive 2002/44/CE on the protection of workers from risks resulting from mechanical vibration].
    Bovenzi M
    Med Lav; 2002; 93(6):551-60. PubMed ID: 12596425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of national legislation on psychosocial risks on organisational action plans, psychosocial working conditions, and employee work-related stress in Europe.
    Jain A; Torres LD; Teoh K; Leka S
    Soc Sci Med; 2022 Jun; 302():114987. PubMed ID: 35500313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Communicable disease policy development in response to changing European political frontiers in Finland, Norway and Sweden.
    Bernitz BK
    Scand J Public Health; 2008 Nov; 36(8):875-8. PubMed ID: 19004906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Institutionalizing policy-level health impact assessment in Europe: is coupling health impact assessment with strategic environmental assessment the next step forward?
    Wright J; Parry J; Scully E
    Bull World Health Organ; 2005 Jun; 83(6):472-7. PubMed ID: 15976899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E-health development policies in new member states in Central Europe.
    Duplaga M
    World Hosp Health Serv; 2007; 43(2):34-8. PubMed ID: 17894192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [What do we know about psychosocial risk factors at work? Part I. Theoretical considerations].
    Potocka A
    Med Pr; 2010; 61(3):341-52. PubMed ID: 20677434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of EU legislation concerning risk assessment and preventive measures in occupational safety and health.
    Niskanen T; Naumanen P; Hirvonen ML
    Appl Ergon; 2012 Sep; 43(5):829-42. PubMed ID: 22233692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.